Table 5 Univariate and multivariate analyses of DFS in MBC patients receiving chemotherapy
DFS | ||||
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR | P value | HR | P value | |
Preoperative chemotherapy | 4.93(1.88–12.89) | < 0.01 | 3.51(1.05–11.75) | 0.04 |
Anthracycline therapy | 1.31(0.17–9.88) | 0.79 | ||
Taxane therapy | 0.73(0.16–3.24) | 0.68 | ||
Platinum therapy | 5.04(1.73–14.69) | < 0.01 | 1.89(0.50–7.18) | 0.35 |